New Launch Site Discount — 50% off sitewide· +10% with Bank Pay
1 / 6
Myogenic Peptides · Performance & Recovery Research
Hexarelin
$60.00$30.00Save 50%
99% Pure | Multi Dose | Finished in the USA
Hexarelin is a synthetic six-amino-acid peptide that binds the ghrelin receptor (GHS-R1a) to trigger robust, reproducible growth-hormone (GH) pulses and cardioprotective signaling in vitro and in vivo. In cardiac-cell and rodent models, Hexarelin enhances GH and IGF-1 release, supports coronary endothelial function, and models anti-apoptotic pathways.
For Research Use Only. Not for human consumption or therapeutic treatment.
99% Pure | Multi Dose | Finished in the USA
Hexarelin is a synthetic six-amino-acid peptide that binds the ghrelin receptor (GHS-R1a) to trigger robust, reproducible growth-hormone (GH) pulses and cardioprotective signaling in vitro and in vivo. In cardiac-cell and rodent models, Hexarelin enhances GH and IGF-1 release, supports coronary endothelial function, and models anti-apoptotic pathways. Each 5 mg vial is HPLC-verified to ≥ 99% purity, and endotoxin-screened (< 0.1 EU/mg), delivering clean, reliable data for GH-axis and cardiovascular research.
What Is Hexarelin Peptide?
Hexarelin is a synthetic GH-releasing peptide that directly activates the ghrelin receptor (GHS-R1a) on pituitary and cardiac cells. Unlike broader secretagogues, Hexarelin provokes strong, reproducible GH surges and engages cardioprotective pathways, making it an ideal research tool for studying both endocrine and cardiovascular models under tightly controlled laboratory conditions.
Why Choose Hexarelin?
Researchers select Hexarelin when they need a dual-action peptide that delivers both robust GH-release and cardioprotective signaling. Its ability to generate clean GH pulses—without significant cortisol or prolactin spikes—combined with documented activity in endothelial-cell and hypoxia assays makes it uniquely versatile. Manufactured and verified to ≥ 99% purity with stringent endotoxin screening, Hexarelin provides reproducible, high-fidelity data for hormone-axis and cardiovascular-health research.
What Sets Hexarelin Apart?
Hexarelin stands out by combining potent GH-axis activation with direct cardiac-cell effects. Its six-residue sequence ensures rapid receptor engagement for growth-hormone release, while also triggering anti-apoptotic and vasodilatory pathways in heart-related models. This unique dual-pathway action—paired with a clean, short-acting profile—allows researchers to dissect endocrine and cardiovascular mechanisms in a single peptide, streamlining study design and enhancing translational relevance.
Research observations
01
Potent GH Release
Hexarelin peptide induces swift GH peaks within 20–30 minutes, enabling precise mapping of downstream IGF-1 dynamics.
02
IGF-1 Signaling
Drives reproducible IGF-1 upregulation in hepatocyte and cardiac myocyte assays, supporting anabolic- and cardioprotective studies.
03
Cardioprotective Modeling
In endothelial-cell cultures, Hexarelin enhances nitric-oxide production and reduces apoptosis under hypoxic stress.
04
Lean-Tissue Anabolism
In muscle-cell assays, it boosts protein-synthesis markers (e.g., AKT/mTOR), modeling anabolic signaling.
05
Endocrine Feedback Analysis
Short half-life (~ 45 minutes) allows repeated dosing to dissect somatostatin feedback without receptor desensitization.
06
Easy Prep & Storage
Reconstitute in sterile or bacteriostatic water; store powder at – 20 °C and solution at 2–8 °C for up to 7 days.
Tested 22-Jul-2026
Kovera · 3 reports
2 earlier
CompoundHexarelin
Research areaMyogenic Peptides, Performance & Recovery Research, Growth Hormone Secretagogue Peptides, Growth Factor & Tissue Signaling Research
FormatLyophilised powder, sealed glass vial
Sizes5mg
Reconstituted shelf life30 days at 2–8°C
Independent laboratoryFreedom Diagnostics and Kovera
Lab reports on file3 reports
Ships fromSaint Petersburg, FL and California
DispatchWithin 24 hours
To study GH-release dynamics, IGF-1 signaling, and cardioprotective pathways in cell and animal models.
GH peaks occur within 20–30 minutes after dosing in culture or rodent assays.
Enhances nitric-oxide production and reduces apoptosis under hypoxic stress, modeling cardiac protection.
Yes—GH surges induced by Hexarelin lead to consistent IGF-1 increases in hepatic and muscle assays.
In vitro: 100 nM–1 µM; in vivo rodent: 0.1–1 mg/kg, per protocol.
Dissolve in Sterile Water for Injection (SWFI) or Bacteriostatic Water (BAC) and mix gently until clear.
Store lyophilized at – 20 °C; keep reconstituted solution at 2–8 °C and use within 7 days.
It provokes GH without significant cortisol or prolactin elevation—ensuring GH-axis–specific data.
Can Hexarelin be combined with GHRH analogs?
Real Peptides offers Hexarelin (5 mg), ≥ 99% purity, and low endotoxin—available for research use only.
1 / 6
